The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma

PLoS Currents

Volumn , Issue APR 2013, 2013, Pages

  Harbour, J William ^a   Chen, Royce ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER EPIDEMIOLOGY; CANCER PROGNOSIS; FINE NEEDLE ASPIRATION BIOPSY; GENE EXPRESSION PROFILING; HUMAN; MULTICENTER STUDY (TOPIC); PATIENT CARE; PERSONALIZED MEDICINE; RISK ASSESSMENT; SYSTEMATIC REVIEW (TOPIC); TUMOR CLASSIFICATION; UVEA MELANOMA;

EID: 84876178516     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/currents.eogt.af8ba80fc776c8f1ce8f5dc485d4a618     Document Type: Article

References (36)

1. Ramaiya KJ, Harbour JW (2007) Current management of uveal melanoma. Expert Review of Ophthalmology 2: 939-946.
2. Kujala E, Makitie T, Kivela T (2003) Very Long-Term Prognosis of Patients with Malignant Uveal Melanoma. Investigative Ophthalmology and Visual Science 44: 4651-4659.
3. Finger PT (2009) The 7th edition AJCC staging system for eye cancer: an international language for ophthalmic oncology. Arch Pathol Lab Med 133: 1197-1198.
4. Midena E, Bonaldi L, Parrozzani R, Tebaldi E, Boccassini B, et al. (2006) In vivo detection of monosomy 3 in eyes with medium-sized uveal melanoma using transscleral fine needle aspiration biopsy. Eur J Ophthalmol 16: 422-425.
5. Young TA, Rao NP, Glasgow BJ, Moral JN, Straatsma BR (2007) Fluorescent in situ hybridization for monosomy 3 via 30-gauge fine-needle aspiration biopsy of choroidal melanoma in vivo. Ophthalmology 114: 142-146.
6. Dopierala J, Damato BE, Lake SL, Taktak AF, Coupland SE (2010) Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification. Invest Ophthalmol Vis Sci 51: 4898-4905.
7. Maat W, Jordanova ES, van Zelderen-Bhola SL, Barthen ER, Wessels HW, et al. (2007) The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies. Arch Pathol Lab Med 131: 91-96.
8. Damato B, Dopierala JA, Coupland SE (2010) Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res 16: 6083-6092.
9. Augsburger JJ, Correa ZM, Shaikh AH (2009) Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol 148: 119-127.
10. Onken MD, Worley LA, Tuscan MD, Harbour JW (2010) An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn 12: 461-468.
11. Onken M, Worley L, Char D, Augsburger J, Correa Z, et al. (2012) Collaborative Ocular Oncology Group Report No. 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal Melanoma. Ophthalmology e-pub ahead of print 20 April 2012; doi: 10.1016/j.ophtha.2012.02.017.
12. Onken MD, Worley LA, Ehlers JP, Harbour JW (2004) Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 64: 7205-7209.
13. Chang SH, Worley LA, Onken MD, Harbour JW (2008) Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis. Melanoma Res 18: 191-200.
14. Onken MD, Ehlers JP, Worley LA, Makita J, Yokota Y, et al. (2006) Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas. Cancer Res 66: 4602-4609.
15. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM (1988) Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 32: 239-251.
16. Kath R, Hayungs J, Bornfeld N, Sauerwein W, Hoffken K, et al. (1993) Prognosis and treatment of disseminated uveal melanoma. Cancer 72: 2219-2223.
17. Gill HS, Char DH (2012) Uveal melanoma prognostication: from lesion size and cell type to molecular class. Can J Ophthalmol 47: 246-253.
18. Worley LA, Onken MD, Person E, Robirds D, Branson J, et al. (2007) Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clinical cancer research: an official journal of the American Association for Cancer Research 13: 1466-1471.
19. Petrausch U, Martus P, Tonnies H, Bechrakis NE, Lenze D, et al. (2007) Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases. Eye 22: 997-1007.
20. van Gils W, Lodder EM, Mensink HW, Kilic E, Naus NC, et al. (2008) Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis. Invest Ophthalmol Vis Sci 49: 4254-4262.
21. Schoenfield L PJ, Tubbs RR, Singh AD (2009) Variation of monosomy 3 status within uveal melanoma. Arch Pathol Lab Med. pp. 1219-1222.
22. Mensink HW VJ, Kilic E, Naus NC, Mooy N, Luyten G, Bruggenwirth HT, Paridaens D, de Klein A (2009) Chromosome 3 intratumor heterogeneity in uveal melanoma. Invest Ophthalmol Vis Sci 50: 500-504.
23. Worley LA, Onken MD, Person E, Robirds D, Branson J, et al. (2007) Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma Clin Cancer Res 13: 1466-1471.
24. Onken MD, Worley L, Harbour JW (2008) A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis Clin Cancer Res 14: 3737-3745.
25. Febbo PG, Ladanyi M, Aldape KD, De Marzo AM, Hammond ME, et al. (2011) NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology. J Natl Compr Canc Netw 9 Suppl 5: S1-32; quiz S33.
26. Beran TM, McCannel TA, Stanton AL, Straatsma BR, Burgess BL (2009) Reactions to and desire for prognostic testing in choroidal melanoma patients. J Genet Couns 18: 265-274.
27. Cook SA, Damato B, Marshall E, Salmon P (2009) Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research. Eye (Lond) 23: 581-585.
28. Mahipal A, Tijani L, Chan K, Laudadio M, Mastrangelo MJ, et al. (2012) A pilot study of sunitinib malate in patients with metastatic uveal melanoma. Melanoma Res 22: 440-446.
29. Heusner TA, Antoch G, Wittkowski-Sterczewski A, Ladd SC, Forsting M, et al. (2011) Transarterial hepatic chemoperfusion of uveal melanoma metastases: survival and response to treatment. Rofo 183: 1151-1160.
30. Danielli R, Ridolfi R, Chiarion-Sileni V, Queirolo P, Testori A, et al. (2011) Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy. Cancer Immunol Immunother.
31. Dayani PN, Gould JE, Brown DB, Sharma KV, Linette GP, et al. (2009) Hepatic metastasis from uveal melanoma: angiographic pattern predictive of survival after hepatic arterial chemoembolization. Arch Ophthalmol 127: 628-632.
32. Radboud University. Messenger ribonucleic acid (mRNA) transfected dendritic cell vaccination in high risk uveal melanoma patients. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2012- [cited 2013 Mar 21]. NLM Identifier:NCT00929019.
33. M.D. Anderson Cancer Center. Phase I/II Study of Ipilimumab for Uveal Melanoma. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2012- [cited 2013 Mar 21]. NLM Identifier:NCT01585194.
34. Aaberg TM. Retina 2012 Subspecialty Day: The Winds of Change. Practical Approaches to Needle Biopsy and Genetic Diagnosis for Ocular Melanoma; 2012; Chicago, IL. pp. 106-114.
35. My Uveal Melanoma website. Retrieved March 21, 2013.
36. Castle Biosciences website. Test for Uveal Melanoma (DecisionDx-UM). Retrieved March 21, 2013.